BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8640738)

  • 1. Expression and the role of cathepsin H in human glioma progression and invasion.
    Sivaparvathi M; Sawaya R; Gokaslan ZL; Chintala SK; Rao JS
    Cancer Lett; 1996 Jun; 104(1):121-6. PubMed ID: 8640738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.
    Sivaparvathi M; Yamamoto M; Nicolson GL; Gokaslan ZL; Fuller GN; Liotta LA; Sawaya R; Rao JS
    Clin Exp Metastasis; 1996 Jan; 14(1):27-34. PubMed ID: 8521613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression and localization of cathepsin B during the progression of human gliomas.
    Sivaparvathi M; Sawaya R; Wang SW; Rayford A; Yamamoto M; Liotta LA; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1995 Jan; 13(1):49-56. PubMed ID: 7820956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cathepsin D during the progression of human gliomas.
    Sivaparvathi M; Sawaya R; Chintala SK; Go Y; Gokaslan ZL; Rao JS
    Neurosci Lett; 1996 Apr; 208(3):171-4. PubMed ID: 8733297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin L in glioma progression: comparison with cathepsin B.
    Strojnik T; Kavalar R; Trinkaus M; Lah TT
    Cancer Detect Prev; 2005; 29(5):448-55. PubMed ID: 16183211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal enzymes, cathepsins in brain tumour invasion.
    Levicar N; Strojnik T; Kos J; Dewey RA; Pilkington GJ; Lah TT
    J Neurooncol; 2002 May; 58(1):21-32. PubMed ID: 12160137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.
    Di Piazza M; Mader C; Geletneky K; Herrero Y Calle M; Weber E; Schlehofer J; Deleu L; Rommelaere J
    J Virol; 2007 Apr; 81(8):4186-98. PubMed ID: 17287256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas.
    del Re EC; Shuja S; Cai J; Murnane MJ
    Br J Cancer; 2000 Apr; 82(7):1317-26. PubMed ID: 10755408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.
    Gole B; Durán Alonso MB; Dolenc V; Lah T
    Pathol Oncol Res; 2009 Dec; 15(4):711-23. PubMed ID: 19434518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B expression and localization in glioma progression and invasion.
    Rempel SA; Rosenblum ML; Mikkelsen T; Yan PS; Ellis KD; Golembieski WA; Sameni M; Rozhin J; Ziegler G; Sloane BF
    Cancer Res; 1994 Dec; 54(23):6027-31. PubMed ID: 7954439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
    Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
    Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
    Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
    Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cathepsin H activity in the human brain and human brain neoplasms].
    Chernaia VI; Reva AD
    Ukr Biokhim Zh (1978); 1989; 61(5):47-50. PubMed ID: 2588347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin B and glioma invasion.
    Demchik LL; Sameni M; Nelson K; Mikkelsen T; Sloane BF
    Int J Dev Neurosci; 1999; 17(5-6):483-94. PubMed ID: 10571410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
    Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
    J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of cathepsin B in human glioblastoma cell lines.
    Konduri S; Lakka SS; Tasiou A; Yanamandra N; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Int J Oncol; 2001 Sep; 19(3):519-24. PubMed ID: 11494030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin L knockdown enhances curcumin-mediated inhibition of growth, migration, and invasion of glioma cells.
    Fei Y; Xiong Y; Zhao Y; Wang W; Han M; Wang L; Tan C; Liang Z
    Brain Res; 2016 Sep; 1646():580-588. PubMed ID: 27373979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
    Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
    Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
    Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
    Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
    J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.